Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1936-5810
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease ; day:24 ; month:6 ; year:2019 ; pages:1-12
Chemosensory perception ; (24.6.2019), 1-12
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12078-019-09267-7
- URN
-
urn:nbn:de:101:1-2019092418443379732029
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tahmasebi, R.
- Zehetmayer, S.
- Stögmann, Elisabeth
- Lehrner, Johann
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Olfactory identification, cognition, depressive symptoms, and 5-year mortality in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer’s disease
Individual cognitive changes in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease using the reliable change index methodology
Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
Long-term Olfactory Functions in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Klinisch-neuropsychologische Charakterisierung des Subjective Cognitive Decline und des moderaten Verlaufs der Alzheimer-Demenz
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Olfactory identification, cognition, depressive symptoms, and 5-year mortality in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer’s disease
Individual cognitive changes in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease using the reliable change index methodology
Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
Long-term Olfactory Functions in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Klinisch-neuropsychologische Charakterisierung des Subjective Cognitive Decline und des moderaten Verlaufs der Alzheimer-Demenz
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Olfactory identification, cognition, depressive symptoms, and 5-year mortality in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer’s disease
Individual cognitive changes in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease using the reliable change index methodology
Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
Long-term Olfactory Functions in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Klinisch-neuropsychologische Charakterisierung des Subjective Cognitive Decline und des moderaten Verlaufs der Alzheimer-Demenz
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease